Rubius Therapeutics
RUBY
$0.02198
Share price
7.74%
Change (1 day)
-98.28%
Change (1 year)
Categories
Rubius Therapeutics (RUBY) - P/B ratio
P/B ratio as of May 2024 : 0.1314
According to Rubius Therapeutics
's latest financial reports the company has a price-to-book ratio of 0.1314.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Rubius Therapeutics - P/B ratio (from 2018 to 2022)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2022-12-31 | 1.05 | -78.52% |
| 2021-12-31 | 4.87 | 11.96% |
| 2020-12-31 | 4.35 | 56.77% |
| 2019-12-31 | 2.77 | -14.49% |
| 2018-12-31 | 3.24 | |
| 2017-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.81 | 2,035.89% | 🇺🇸 USA |